Conclusions
AL-CA patients had marked reductions in LASr and LASct. LA strain may be helpful in differentiating AL-CA from HHD patients.
Reference
1. Ikura H, Endo J, Kitakata H, Moriyama H, Sano M, Fukuda K. Molecular Mechanism of Pathogenesis and Treatment Strategies for AL Amyloidosis.International journal of molecular sciences. 2022;23(11).
2. Martinez-Naharro A, Baksi AJ, Hawkins PN, Fontana M. Diagnostic imaging of cardiac amyloidosis. Nature reviews Cardiology.2020;17(7):413-426.
3. Rapezzi C, Merlini G, Quarta CC, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.Circulation. 2009;120(13):1203-1212.
4. Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.Blood. 2015;126(20):2345-2347.
5. Quarta CC, Gonzalez-Lopez E, Gilbertson JA, et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis.European heart journal. 2017;38(24):1905-1908.
6. Falk RH. Diagnosis and management of the cardiac amyloidoses.Circulation. 2005;112(13):2047-2060.
7. Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart (British Cardiac Society). 2011;97(1):75-84.
8. Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. Journal of the American College of Cardiology. 2016;68(12):1323-1341.
9. Rausch K, Scalia GM, Sato K, et al. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.The international journal of cardiovascular imaging.2021;37(1):81-90.
10. Nochioka K, Quarta CC, Claggett B, et al. Left atrial structure and function in cardiac amyloidosis. European heart journal Cardiovascular Imaging. 2017;18(10):1128-1137.
11. Kobayashi Y, Moneghetti KJ, Boralkar K, et al. Challenging the complementarity of different metrics of left atrial function: insight from a cardiomyopathy-based study. European heart journal Cardiovascular Imaging. 2017;18(10):1153-1162.
12. de Gregorio C, Dattilo G, Casale M, Terrizzi A, Donato R, Di Bella G. Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy - Comparative Strain Imaging Study. Circulation journal : official journal of the Japanese Circulation Society.2016;80(8):1830-1837.
13. Brand A, Frumkin D, Hübscher A, et al. Phasic left atrial strain analysis to discriminate cardiac amyloidosis in patients with unclear thick heart pathology. European heart journal Cardiovascular Imaging. 2021;22(6):680-687.
14. Aimo A, Fabiani I, Giannoni A, et al. Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis. European heart journal Cardiovascular Imaging.2022;24(1):130-141.
15. Tadic M, Cuspidi C, Marwick TH. Phenotyping the hypertensive heart.European heart journal. 2022;43(38):3794-3810.
16. Iio C, Inoue K, Nishimura K, et al. Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography. Echocardiography (Mount Kisco, NY).2015;32(12):1821-1830.
17. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2015;28(1):1-39.e14.
18. Kawakami H, Ramkumar S, Nolan M, et al. Left Atrial Mechanical Dispersion Assessed by Strain Echocardiography as an Independent Predictor of New-Onset Atrial Fibrillation: A Case-Control Study.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.2019;32(10):1268-1276.e1263.
19. Marek J, Palecek T, Magne J, et al. Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis.Echocardiography (Mount Kisco, NY). 2018;35(11):1755-1763.
20. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European heart journal Cardiovascular Imaging. 2016;17(12):1321-1360.
21. Fan JL, Su B, Zhao X, et al. Correlation of left atrial strain with left ventricular end-diastolic pressure in patients with normal left ventricular ejection fraction. The international journal of cardiovascular imaging. 2020;36(9):1659-1666.
22. Gan GCH, Bhat A, Chen HHL, et al. Determinants of LA reservoir strain: Independent effects of LA volume and LV global longitudinal strain. Echocardiography (Mount Kisco, NY).2020;37(12):2018-2028.
23. Pandozi C, Santini M. Update on atrial remodelling owing to rate; does atrial fibrillation always ’beget’ atrial fibrillation?European heart journal. 2001;22(7):541-553.
24. Hoit BD. Left atrial size and function: role in prognosis.Journal of the American College of Cardiology.2014;63(6):493-505.
25. Cameli M, Mandoli GE, Loiacono F, Sparla S, Iardino E, Mondillo S. Left atrial strain: A useful index in atrial fibrillation.International journal of cardiology. 2016;220:208-213.
26. Kuppahally SS, Akoum N, Burgon NS, et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circulation Cardiovascular imaging.2010;3(3):231-239.